Epiliquid Holding, Inc

This study is testing a new blood test called Delta-HLD to see how well it can detect colorectal cancer in average-risk people aged 45 to 75. About 3,200 participants will give a blood sample before their scheduled screening colonoscopy. The test results will be compared to the c…

This study is testing a new blood test called delta-HLD to see how well it can detect liver cancer (hepatocellular carcinoma). Researchers will compare results from 200 people—some with liver cancer and some with liver cirrhosis but no cancer—to measure the test's accuracy. If su…